186 related articles for article (PubMed ID: 23209205)
41. In vitro susceptibility of Coxiella burnetii to linezolid in comparison with its susceptibilities to quinolones, doxycycline, and clarithromycin.
Gikas A; Spyridaki I; Scoulica E; Psaroulaki A; Tselentis Y
Antimicrob Agents Chemother; 2001 Nov; 45(11):3276-8. PubMed ID: 11600400
[TBL] [Abstract][Full Text] [Related]
42. Therapeutic impact of the correlation of doxycycline serum concentrations and the decline of phase I antibodies in Q fever endocarditis.
Lecaillet A; Mallet MN; Raoult D; Rolain JM
J Antimicrob Chemother; 2009 Apr; 63(4):771-4. PubMed ID: 19218274
[TBL] [Abstract][Full Text] [Related]
43. Identification of rickettsiae isolated in Japan as Coxiella burnetii by 16S rRNA sequencing.
Masuzawa T; Sawaki K; Nagaoka H; Akiyama M; Hirai K; Yanagihara Y
Int J Syst Bacteriol; 1997 Jul; 47(3):883-4. PubMed ID: 9226923
[TBL] [Abstract][Full Text] [Related]
44. Clinically and histologically silent Q fever endocarditis accidentally diagnosed by PCR.
Issartel B; Gauduchon V; Chalabreysse L; Célard M; Ninet J; Lepidi H; Etienne J; Vandenesch F
Clin Microbiol Infect; 2002 Feb; 8(2):113-4. PubMed ID: 11952725
[TBL] [Abstract][Full Text] [Related]
45. [Acute and chronic Q fever; epidemiology, symptoms, diagnosis and therapy of infection caused by Coxiella burnetii].
Bartelink AK; Stevens H; van Kregten E; Meijer JG; Beeres MP; van Deuren M
Ned Tijdschr Geneeskd; 2000 Jul; 144(27):1303-6. PubMed ID: 10918908
[TBL] [Abstract][Full Text] [Related]
46. Coinfection with Coxiella burnetii in infectious endocarditis.
Rovery C; Granel B; Casalta JP; Lepidi H; Habib G; Raoult D
Clin Microbiol Infect; 2009 Dec; 15 Suppl 2():190-1. PubMed ID: 19548994
[No Abstract] [Full Text] [Related]
47. Q fever: persistence of antigenic non-viable cell residues of Coxiella burnetii in the host--implications for post Q fever infection fatigue syndrome and other chronic sequelae.
Marmion BP; Sukocheva O; Storm PA; Lockhart M; Turra M; Kok T; Ayres J; Routledge H; Graves S
QJM; 2009 Oct; 102(10):673-84. PubMed ID: 19556396
[TBL] [Abstract][Full Text] [Related]
48. Is plasmid based differentiation of Coxiella burnetii in 'acute' and 'chronic' isolates still valid?
Thiele D; Willems H
Eur J Epidemiol; 1994 Aug; 10(4):427-34. PubMed ID: 7843346
[TBL] [Abstract][Full Text] [Related]
49. [Drug activity against Coxiella burnetii, a pathogen of Q fever].
Tokarevich NK
Antibiot Khimioter; 2007; 52(1-2):46-56. PubMed ID: 18461810
[No Abstract] [Full Text] [Related]
50. Molecular detection of Coxiella burnetii in the sera of patients with Q fever endocarditis or vascular infection.
Fenollar F; Fournier PE; Raoult D
J Clin Microbiol; 2004 Nov; 42(11):4919-24. PubMed ID: 15528674
[TBL] [Abstract][Full Text] [Related]
51. Coxiella burnetii survives in monocytes from patients with Q fever endocarditis: involvement of tumor necrosis factor.
Dellacasagrande J; Ghigo E; Capo C; Raoult D; Mege JL
Infect Immun; 2000 Jan; 68(1):160-4. PubMed ID: 10603382
[TBL] [Abstract][Full Text] [Related]
52. Immunohistologic demonstration of Coxiella burnetii in the valves of patients with Q fever endocarditis.
Brouqui P; Dumler JS; Raoult D
Am J Med; 1994 Nov; 97(5):451-8. PubMed ID: 7977434
[TBL] [Abstract][Full Text] [Related]
53. Comparison of Japanese isolates of Coxiella burnetii by PCR-RFLP and sequence analysis.
Andoh M; Nagaoka H; Yamaguchi T; Fukushi H; Hirai K
Microbiol Immunol; 2004; 48(12):971-5. PubMed ID: 15611614
[TBL] [Abstract][Full Text] [Related]
54. Eight new genomes and synthetic controls increase the accessibility of rapid melt-MAMA SNP typing of Coxiella burnetii.
Karlsson E; Macellaro A; Byström M; Forsman M; Frangoulidis D; Janse I; Larsson P; Lindgren P; Ohrman C; van Rotterdam B; Sjödin A; Myrtennäs K
PLoS One; 2014; 9(1):e85417. PubMed ID: 24465554
[TBL] [Abstract][Full Text] [Related]
55. Conventional viral cultures and shell vial assay for diagnosis of apparently culture-negative Coxiella burnetii endocarditis.
Gil-Grande R; Aguado JM; Pastor C; García-Bravo M; Gómez-Pellico C; Soriano F; Noriega AR
Eur J Clin Microbiol Infect Dis; 1995 Jan; 14(1):64-7. PubMed ID: 7729459
[TBL] [Abstract][Full Text] [Related]
56. Q fever bioprosthetic aortic valve endocarditis (PVE) successfully treated with doxycycline monotherapy.
Krol V; Kogan V; Cunha BA
Heart Lung; 2008; 37(2):157-60. PubMed ID: 18371509
[TBL] [Abstract][Full Text] [Related]
57. First Case of Q Fever Endocarditis Involving the Melody
Jalal Z; Duperril M; Séguéla PE; Melenotte C; Chabaneix J; Raoult D; Thambo JB
Pediatr Cardiol; 2018 Jan; 39(1):195-197. PubMed ID: 28948320
[TBL] [Abstract][Full Text] [Related]
58. [Late recurrence of endocarditis caused by Coxiella burnetii following prosthetic valve substitution and prolonged antibiotic treatment].
Abril V; Ortega E; Segarra P; Fraile T
Enferm Infecc Microbiol Clin; 1999 Jan; 17(1):44-5. PubMed ID: 10069116
[No Abstract] [Full Text] [Related]
59. Late relapse of Q fever endocarditis.
Morguet AJ; Jansen A; Raoult D; Schneider T
Clin Res Cardiol; 2007 Jul; 96(7):519-21. PubMed ID: 17453129
[No Abstract] [Full Text] [Related]
60. Successful surgical treatment of Q fever endocarditis with mitral valve repair.
Khan JN; Tapp LD; Glancy JM; Prasad N; Bailey MS; Graham TR
J R Army Med Corps; 2012 Jun; 158(2):132-4. PubMed ID: 22860505
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
